Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Sjögren

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 5, 2022
Overview of authorized drug products for subcutaneous administration: Pharmaceutical, therapeutic, and physicochemical propertiesIlse R Dubbelboer, Erik Sjögren
International Journal of Pharmaceutics|May 9, 2022
Physiological based pharmacokinetic and biopharmaceutics modelling of subcutaneously administered compounds - An overview of in silico modelsIlse R Dubbelboer, Erik Sjögren
Molecular Pharmaceutics|March 2, 2016
In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption ModelsErik Sjögren, Helena Thörn, Christer Tannergren
Molecular Pharmaceutics|December 17, 2016
Reply to "Comment on 'In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models'"Erik Sjögren, Helena Thörn, Christer Tannergren
International Journal of Pharmaceutics|February 13, 2026
Rational formulation design through retrospective machine learning methodology: Case study ibuprofenDylan Garamani, Erik Sjögren, Albert Mihranyan
ADMET & DMPK|March 18, 2022
Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on <i>in vivo</i> data from intestinal perfusion modelsDavid Dahlgren, Erik Sjögren, Hans Lennernäs
Molecular Pharmaceutics|February 23, 2012
The pharmacokinetics and hepatic disposition of repaglinide in pigs: mechanistic modeling of metabolism and transportErik Sjögren, Ulf Bredberg, Hans Lennernäs
CPT: Pharmacometrics & Systems Pharmacology|June 25, 2026
Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology FrameworkMoriah Pellowe, Ilse Dubbelboer, Erik Sjögren
Pharmaceutics|January 25, 2025
Whole-Body Physiologically Based Pharmacokinetic Modeling of GalNAc-Conjugated siRNAsEmilie Langeskov Salim, Kim Kristensen, Erik Sjögren
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 4, 2012
Optimized experimental design for the estimation of enzyme kinetic parameters: an experimental evaluationErik Sjögren, Petter Svanberg, Kajsa P Kanebratt
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 5, 2022
Overview of authorized drug products for subcutaneous administration: Pharmaceutical, therapeutic, and physicochemical propertiesIlse R Dubbelboer, Erik Sjögren
International Journal of Pharmaceutics|May 9, 2022
Physiological based pharmacokinetic and biopharmaceutics modelling of subcutaneously administered compounds - An overview of in silico modelsIlse R Dubbelboer, Erik Sjögren
Molecular Pharmaceutics|March 2, 2016
In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption ModelsErik Sjögren, Helena Thörn, Christer Tannergren
Molecular Pharmaceutics|December 17, 2016
Reply to "Comment on 'In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models'"Erik Sjögren, Helena Thörn, Christer Tannergren
International Journal of Pharmaceutics|February 13, 2026
Rational formulation design through retrospective machine learning methodology: Case study ibuprofenDylan Garamani, Erik Sjögren, Albert Mihranyan
ADMET & DMPK|March 18, 2022
Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on <i>in vivo</i> data from intestinal perfusion modelsDavid Dahlgren, Erik Sjögren, Hans Lennernäs
Molecular Pharmaceutics|February 23, 2012
The pharmacokinetics and hepatic disposition of repaglinide in pigs: mechanistic modeling of metabolism and transportErik Sjögren, Ulf Bredberg, Hans Lennernäs
CPT: Pharmacometrics & Systems Pharmacology|June 25, 2026
Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology FrameworkMoriah Pellowe, Ilse Dubbelboer, Erik Sjögren
Pharmaceutics|January 25, 2025
Whole-Body Physiologically Based Pharmacokinetic Modeling of GalNAc-Conjugated siRNAsEmilie Langeskov Salim, Kim Kristensen, Erik Sjögren
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 4, 2012
Optimized experimental design for the estimation of enzyme kinetic parameters: an experimental evaluationErik Sjögren, Petter Svanberg, Kajsa P Kanebratt
Pageof 8